share_log

In8bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-William Tai-Wei Ho(7.1%)

In8bio | SC 13G/A:超過5%持股股東披露文件(修正)-William Tai-Wei Ho(7.1%)

SEC announcement ·  02/14 05:06
牛牛AI助理已提取核心訊息
William Tai-Wei Ho has filed an amended Schedule 13G with the United States Securities and Exchange Commission on February 13, 2024, indicating a change in his holdings of In8bio, Inc. As of December 31, 2023, Ho reported beneficial ownership of 3,126,505 shares of In8bio's common stock, which represents 7.1% of the company's class of securities. This stake includes 2,421,512 shares held directly, 449,494 shares underlying immediately exercisable options, and additional shares held by Ho's minor children and other relatives. The filing was made in accordance with the Securities Exchange Act of 1934 and reflects Ho's holdings as of the end of 2023. In8bio, Inc., headquartered at 350 5th Avenue, Suite 5330, New York, NY, is a Delaware corporation listed on the United States stock market.
William Tai-Wei Ho has filed an amended Schedule 13G with the United States Securities and Exchange Commission on February 13, 2024, indicating a change in his holdings of In8bio, Inc. As of December 31, 2023, Ho reported beneficial ownership of 3,126,505 shares of In8bio's common stock, which represents 7.1% of the company's class of securities. This stake includes 2,421,512 shares held directly, 449,494 shares underlying immediately exercisable options, and additional shares held by Ho's minor children and other relatives. The filing was made in accordance with the Securities Exchange Act of 1934 and reflects Ho's holdings as of the end of 2023. In8bio, Inc., headquartered at 350 5th Avenue, Suite 5330, New York, NY, is a Delaware corporation listed on the United States stock market.
何大偉已於2024年2月13日向美國證券交易委員會提交了經修訂的附表13G,表明他在In8Bio, Inc.的持股量發生了變化。截至2023年12月31日,何大偉報告了In8Bio普通股的3,126,505股實益所有權,佔該公司證券類別的7.1%。該股份包括直接持有的2,421,512股股份、標的可立即行使的期權的449,494股股份,以及何的未成年子女和其他親屬持有的額外股份。該文件是根據1934年的《證券交易法》提交的,反映了何先生截至2023年底的持股情況。in8bio, Inc. 總部位於紐約州紐約第五大道350號5330套房,是一家在美國股票市場上市的特拉華州公司。
何大偉已於2024年2月13日向美國證券交易委員會提交了經修訂的附表13G,表明他在In8Bio, Inc.的持股量發生了變化。截至2023年12月31日,何大偉報告了In8Bio普通股的3,126,505股實益所有權,佔該公司證券類別的7.1%。該股份包括直接持有的2,421,512股股份、標的可立即行使的期權的449,494股股份,以及何的未成年子女和其他親屬持有的額外股份。該文件是根據1934年的《證券交易法》提交的,反映了何先生截至2023年底的持股情況。in8bio, Inc. 總部位於紐約州紐約第五大道350號5330套房,是一家在美國股票市場上市的特拉華州公司。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。